Abstract | PURPOSE: PATIENTS AND METHODS: A consecutive series of 42 patients treated with TENS for refractory OAB was prospectively investigated at an academic tertiary referral centre. Effects were evaluated using bladder diary for at least 48 h and satisfaction assessment at baseline, after 12 weeks of TENS treatment, and at the last known follow-up. Adverse events related to TENS were also assessed. RESULTS: Mean age of the 42 patients (25 women, 17 men) was 48 years (range, 18-76). TENS was successful following 12 weeks of treatment in 21 (50 %) patients, and the positive effect was sustained during a mean follow-up of 21 months (range, 6-83 months) in 18 patients. Following 12 weeks of TENS treatment, mean number of voids per 24 h decreased significantly from 15 to 11 (p < 0.001) and mean voided volume increased significantly from 160 to 230 mL (p < 0.001). In addition, TENS completely restored continence in 7 (39 %) of the 18 incontinent patients. Before TENS, all 42 patients were dissatisfied or very dissatisfied; following 12 weeks of TENS treatment, 21 (50 %) patients felt satisfied or very satisfied (p < 0.001). No adverse events related to TENS were noted. CONCLUSIONS:
TENS seems to be an effective and safe treatment for refractory OAB warranting randomized, placebo-controlled trials.
|
Authors | Marc Tellenbach, Marc Schneider, Livio Mordasini, George N Thalmann, Thomas M Kessler |
Journal | World journal of urology
(World J Urol)
Vol. 31
Issue 5
Pg. 1205-10
(Oct 2013)
ISSN: 1433-8726 [Electronic] Germany |
PMID | 22622396
(Publication Type: Clinical Trial, Journal Article)
|
Topics |
- Adolescent
- Adult
- Aged
- Female
- Follow-Up Studies
- Humans
- Male
- Medical Records
- Middle Aged
- Patient Satisfaction
- Prospective Studies
- Syndrome
- Transcutaneous Electric Nerve Stimulation
(adverse effects, methods)
- Treatment Outcome
- Urinary Bladder, Overactive
(therapy)
- Young Adult
|